Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Positive Independent Data Safety Moni
DGAP-News: Vivoryon Therapeutics N.V. / Key word(s): Research UpdateVivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Positive Independent Data Safety Monitoring Board Recommendation for Phase 2b Study of Varoglutamstat in AD (news with additional features)23.06.2022 / 07:00 The issuer is solely respons...